Category : Healthcare and Pharmaceuticals | Published at : April-2019 | Delivery Format : PDF | Status: Published | Pages : 160
The global In-Vitro Fertilization (IVF) market is expected to grow at significant CAGR around 9.8 % throughout the forecast period 2018 to 2026 and reach around US$ 38.7 billion by 2026.
The report provides analysis of global In-Vitro Fertilization (IVF) market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year.
In-Vitro Fertilization (IVF) is a type of assisted reproductive technique in which in laboratory environments the ovum is artificially fertilized then implanted into the womb. IVF is one of the most common therapies used for infertility problems in pairs, single mothers, and the LGBT community. The growth of IVF services global is driven by an increase in infertility, the increase in the trend of delayed pregnancies, an increase in IVF success and an increase in available earnings worldwide. However, higher cost, IVF-related complications and low awareness of IVF in certain less developed regions limit the growth of the market.
Market Dynamics
Due to a risen infertility rate, a rise in delayed pregnancies, an increase in IVF success rate, and a world-wide rise in disposable revenues, the global IVF services market is expected to grow significantly during this period. In some developing regions the growth of the IVF service market is hampered by high cost, IVF-related complications and low IVF awareness. Inverse, the growth of fertility tourism, increased fertility clinics and the potential for growth in emerging markets will make way for the development of the IVF services market in the future.
North America is anticipated to govern the In-Vitro Fertilization (IVF) Market
Most IVF requirements are imported in developing African regions and can only be used once in each cycle. The incidence of infertility in Nigeria is about 25% compared with 1015% in the United States and in the UK, according to University of Benin (Nigeria). IVF procedures helped couples manage these high levels of infertility. Low cost of IVF therapy and the rise in fertility tourism trends in South Africa continue to drive Africa's in vitro market growth. On the other hand, lack of funding, poor income, insufficient awareness of IVF, inadequate coverage of health services and lack of educated professionals impede growth in developing economies of Africa.
Market Segmentation
In-Vitro Fertilization (IVF) Market by Instrument
- Culture Media
- Disposable Devices
- Capital Equipment
In-Vitro Fertilization (IVF) Market by Type
- Frozen Non-donor
- Fresh Non-donor
- Frozen Donor
- Fresh Donor
In-Vitro Fertilization (IVF) Market by End-Use
- Fertility Clinics
- Hospitals & others
Global In-Vitro Fertilization (IVF) Market, by Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
The market research study on “In-Vitro Fertilization (IVF) Market (By Instrument: Culture Media, Disposable Devices, Capital Equipment; By Type: Frozen Non-donor, Fresh Non-donor, Frozen Donor, Fresh Donor; By End-Use: Fertility Clinics, Hospitals & others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers detailed insights on global In-Vitro Fertilization (IVF) market segments with market dynamics and their impact. The report provides insights on global In-Vitro Fertilization (IVF) market by instrument SW, type, End-use and major geographic regions.
Irvine Scientific, EMD Serono Inc., and OvaScience are Likely to Continue to Lead the Global IVF Market
The In-Vitro Fertilization (IVF) market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are; EMD Serono Inc.; OvaScience; Genea Biomedx; Vitrolife AB; Irvine Scientific; Thermo Fisher Scientific Inc.; Cook Medical Inc.; Cooper Surgical Inc.; Boston IVF, and Progyny, Inc.
